GlassScriptPhysician profile
Dennis S Sneed
NPI 1023385531
$3,665.20
in general payments reported to CMS, 2019-2025
16 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $864 · 2022: $810 · 2023: $726 · 2024: $742 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $673.45 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $639.17 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Alkermes, INC. | $410.49 | 2021-2023 | Lybalvi |
| Janssen Pharmaceuticals, INC | $375.58 | 2023-2024 | Invega Sustenna, Spravato |
| Axsome Therapeutics, INC. | $369.91 | 2023-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $247.86 | 2021-2024 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $242.99 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $216.85 | 2021-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $124.64 | 2022 | |
| Sunovion Pharmaceuticals INC. | $118.27 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $93.86 | 2021 | |
| Lundbeck LLC | $52.47 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.58 | 2021 | |
| Vanda Pharmaceuticals INC. | $21.28 | 2021 | |
| Luye Pharma (USA) LTD. | $17.33 | 2025 | Erzofri Extended-Release |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $16.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Sneed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.